Home › Compare › XRAPF vs MCD

XRAPF vs MCD: Dividend Comparison 2026

XRAPF yields 44444.44% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 XRAPF wins by $1.4802188700273396e+23M in total portfolio value
10 years
XRAPF
XRAPF
● Live price
44444.44%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4802188700273396e+23M
Annual income
$147,369,615,738,581,320,000,000,000,000.00
Full XRAPF calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — XRAPF vs MCD

📍 XRAPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXRAPFMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XRAPF + MCD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
XRAPF pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XRAPF
Annual income on $10K today (after 15% tax)
$3,777,777.78/yr
After 10yr DRIP, annual income (after tax)
$125,264,173,377,794,110,000,000,000,000.00/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, XRAPF beats the other by $125,264,173,377,794,110,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XRAPF + MCD for your $10,000?

XRAPF: 50%MCD: 50%
100% MCD50/50100% XRAPF
Portfolio after 10yr
$7.401094350136698e+22M
Annual income
$73,684,807,869,290,660,000,000,000,000.00/yr
Blended yield
99.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

XRAPF
No analyst data
Altman Z
-3.9
Piotroski
1/9
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XRAPF buys
0
MCD buys
0
No recent congressional trades found for XRAPF or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXRAPFMCD
Forward yield44444.44% ✓2.35%
Annual dividend / share$2.00$7.26 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3% ✓
Portfolio after 10y$1.4802188700273396e+23M$78.5K ✓
Annual income after 10y$147,369,615,738,581,320,000,000,000,000.00 ✓$26,227.70
Total dividends collected$1.4797905017086652e+23M$58.5K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: XRAPF vs MCD ($10,000, DRIP)

YearXRAPF PortfolioXRAPF Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$4,455,144$4,444,444.44$10,815$334.85+$4.44M → XRAPF
2$1,855,294,292$1,850,527,287.41$11,826$491.71+$1855.28M → XRAPF
3$722,201,114,647$720,215,949,754.98$13,123$730.06+$722201.10M → XRAPF
4$262,786,638,114,837$262,013,882,922,164.10$14,853$1,100.07+$262786638.10M → XRAPF
5$89,382,811,928,504,960$89,101,630,225,722,080.00$17,257$1,690.61+$89382811928.49M → XRAPF
6$28,419,510,536,946,614,000$28,323,870,928,183,110,000.00$20,752$2,667.01+$28419510536946.59M → XRAPF
7$8,446,906,587,814,894,000,000$8,416,497,711,540,360,000,000.00$26,103$4,354.83+$8446906587814894.00M → XRAPF
8$2,346,953,255,508,951,600,000,000$2,337,915,065,459,989,300,000,000.00$34,794$7,437.78+$2346953255508951552.00M → XRAPF
9$609,599,312,292,179,560,000,000,000$607,088,072,308,785,000,000,000,000.00$49,926$13,461.60+$609599312292179607552.00M → XRAPF
10$148,021,887,002,733,950,000,000,000,000$147,369,615,738,581,320,000,000,000,000.00$78,550$26,227.70+$1.4802188700273396e+23M → XRAPF

XRAPF vs MCD: Complete Analysis 2026

XRAPF — Stock

XRApplied Technologies Inc. engages in the development of augmented reality, virtual reality, and mixed reality technologies in Canada and France. Its products include Technology News App, which shares the latest in cutting edge immersive reality products, news, and developments; ARFlooring Made Easy, an app that can overlay flooring options into a photo of any space, so the consumer can see what the product will look like in their home; Balloon Pop, an educational and fun app for children; and Rifters AR Shooting Game, an AR-shooting and role-playing game. The company is headquartered in Vancouver, Canada.

Full XRAPF Calculator →

MCD — Consumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this XRAPF vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XRAPF vs SCHDXRAPF vs JEPIXRAPF vs OXRAPF vs KOXRAPF vs MAINXRAPF vs YUMXRAPF vs QSRXRAPF vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.